Michael Girard is an accomplished academic and researcher in the field of biomedical engineering and ophthalmology. Currently serving as an Associate Professor at Duke-NUS Medical School and an Adjunct Scientist at the Institute of Molecular and Clinical Ophthalmology Basel since December 2020, Michael also leads the Ophthalmic Engineering & Innovation Laboratory at the Singapore National Eye Centre, where responsibilities include principal investigator and co-head of the Bioengineering and Devices Research Group. Michael founded Abyss Processing in November 2015, specializing in 3D AI solutions for glaucoma. Previous experience includes roles as an Assistant Professor at the National University of Singapore and a Junior Research Fellow at Imperial College London. Michael holds a PhD in Biomedical Engineering from Tulane University and an MSc in Mechanical Engineering from Ecole Polytechnique Universitaire de Lyon.
This person is not in any offices
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. The institute is constituted as a foundation. IOB started operations in 2018. At IOB, we accelerate the conversion of basic research into innovative treatments which change the field of ophthalmic therapy. Interdisciplinary teams of researchers and clinicians work hand in hand. These problem-solvers and innovators have in-depth knowledge of unmet medical needs, and daily exposure to patients. Together, they improve the understanding of vision, and of the cells involved in eye disease. In this highly collaborative environment, IOB turns discoveries and technologies into clinical benefits for patients with blinding conditions. We help advance the practice of ophthalmic disease based on the genetic, structural and functional understanding of the cell types and their interactions within the human eye. At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of eye diseases and to develop new therapies for vision loss.